Welcome to our dedicated page for Crescent Cap Bdc SEC filings (Ticker: FCRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Crescent Cap Bdc's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Crescent Cap Bdc's regulatory disclosures and financial reporting.
Crescent Capital BDC, Inc. is calling a fully virtual 2026 annual stockholders meeting on May 15, 2026, at 10:00 a.m. Pacific Time. Stockholders will vote on electing Class II directors Susan Yun Lee and Michael S. Segal to terms running to the 2029 meeting and on ratifying Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is March 18, 2026, when 36,969,285 common shares were outstanding, with one vote per share. The Board and all independent directors unanimously recommend voting FOR both director nominees and FOR ratification of E&Y. The proxy also outlines governance structure, committee responsibilities, related-party advisory and administration agreements, and the external management fee and incentive fee arrangements with Crescent Cap Advisors, LLC.
Crescent Capital BDC, Inc. has issued two new series of senior unsecured notes and arranged a third under a note purchase supplement. The supplement covers up to $67.5 million of Tranche A notes due February 13, 2029, $67.5 million of Tranche B notes due February 13, 2031, and $50.0 million of Tranche C notes due May 22, 2029.
The Tranche A notes carry a fixed rate of 5.87% and the Tranche B notes a fixed rate of 6.20%. The Tranche A and Tranche B notes were issued on February 13, 2026, while issuance of the Tranche C notes is expected on May 22, 2026, subject to customary closing conditions.
To manage interest exposure, the company entered into interest rate swaps on each of Tranche A and Tranche B for notional amounts of $67.5 million. For Tranche A it will receive fixed 5.87% and pay three month term SOFR plus 2.5325% through February 13, 2029. For Tranche B it will receive fixed 6.20% and pay three month term SOFR plus 2.8050% through February 13, 2031.
Crescent Capital BDC, Inc. reported lower results for the year ended December 31, 2025, with net investment income of $1.81 per share and net income of $0.93 per share, down from $2.40 and $1.99 per share in 2024. Investment income fell to $167.3 million from $197.4 million, mainly because benchmark interest rates declined and certain debt investments were restructured. Net asset value per share declined to $19.10 from $19.98 as credit marks and foreign currency hedges weighed on results. For the fourth quarter of 2025, net investment income was $0.45 per share and net income was $0.23 per share. The company’s board declared a regular cash dividend of $0.42 per share for the first quarter of 2026, payable April 15, 2026 to shareholders of record on March 31, 2026. At year-end, Crescent BDC held $1.57 billion of investments across 184 portfolio companies, a weighted average yield on income-producing securities of 10.0%, and a debt-to-equity ratio of 1.25x, supported by $31.5 million of cash and $242.0 million of undrawn credit capacity.
Texas County & District Retirement System reports a significant passive stake in Crescent Capital BDC, Inc. It beneficially owns 5,001,752 shares of common stock, representing 13.50% of the class as of 12/31/2025.
The fund has sole power to vote and dispose of all 5,001,752 shares, with no shared voting or dispositive power. It certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Crescent Capital BDC.